Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
9.97
-0.82 (-7.59%)
Mar 31, 2025, 1:41 PM EDT - Market open
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $404.43 million as of March 31, 2025. Its market cap has decreased by -83.39% in one year.
Market Cap
404.43M
Enterprise Value
-136.26M
1-Year Change
-83.39%
Ranking
Category
Stock Price
$9.97
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $404.43M, an increase of 4.96%. That is a compound annual growth rate of 0.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 437.66M | -31.75% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |